Reduced ETO emissions to safeguard biomedical supply chains
Ended Project Grant Awarded Last action
- Award ID
- R44FD007588
- Recipient
-
Sonata Scientific LLC UEI RJK3YJYBMRT6
- Awarding agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Obligated
- $788,507
Award facts
- Assistance listing
- 93.103 Food and Drug Administration Research
- Completion date
- Funding agency
- Center for Biologics Evaluation and Research Food and Drug Administration, Department of Health and Human Services
- Place of performance
- Connecticut, USA
Award details come from USAspending.gov.
Description
- Abstract
- The overarching goal of this project is to protect the nation's supply chain of critical medical devices that are sterilized using ethylene oxide (ETO). Despite the search for alternative approaches, a large fraction of single-use devices is sterilized with ETO. These devices, including catheters, heart valves, and tracheostomy tubes, are critical to routine and life-saving procedures and therapies. As regulations for ETO emissions become more stringent to protect workers and communities from harmful exposure, there is a significant risk that supply chains for critical devices will be disrupted, in turn threatening the health and well-being of the nation. The specific objectives of this project include the development of a novel photocatalytic system to mitigate ETO at levels that are hazardous but difficult to address with existing adsorptive and thermal catalytic approaches. Specifically, the technology addresses concentrations in the range of 5 PPM and below in sterilization facilities, transportation, and warehouses. These "fugitive emissions" are a significant contributor to overall emissions and directly impact workers and community safety. Objectives include determining operating conditions at which low concentrations of ETO (
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$2,493 | |
| Amendment | $200,000 | |
| Original award | $591,000 |
Quick answers
Who received award R44FD007588?
R44FD007588 was awarded to Sonata Scientific LLC by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 20, 2022.
How much is award R44FD007588 worth?
$788,507 has been obligated on R44FD007588.
Which agency awarded R44FD007588?
FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded R44FD007588, with funding from Center for Biologics Evaluation and Research (Food and Drug Administration).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award